We are pleased to announce the availability of the above-mentioned report, which came out in June 2013. Published since 1984, the Worldwide Plasma Proteins Market report has been updated with data collected in some fifty countries over the last three years. It provides sales data in units, dollars, and market shares by company and by region for each of the therapeutic plasma and recombinant proteins listed below. A ten year price history of the main products is also provided.

• Polyvalent Intravenous and Subcutaneous Immune Globulin (IVIG/SCIG)
• Hyperimmune Globulins (Tetanus, Rho(D), Hepatitis B, Rabies, etc.

• Albumin
• Factor VIII and Factor IX (plasma-derived and recombinant)
• von Willebrand Factor,
• Prothrombin Complex
• Activated Prothrombin Complex and recombinant Factor VIIa

• Antithrombin III
• Alpha-1 Antitrypsin

• C1-Esterase Inhibitor (C1-INH)
• Fibrin Adhesive,
• Thrombin and Other Products

This study analyzes recent industry developments that have led the global plasma protein market to grow from about $11.8 billion to $15.2 billion between 2008 and 2012. Its table of contents is enclosed.





JUNE 2013


Executive Summary
Worldwide market by Region
Worldwide market by Product
Worldwide market by Company
Company Profiles
Polyvalent Subcutaneous Immune Globulin (SCIG)
Polyvalent Intravenous Immune Globulin (IVIG)
Polyvalent Intramuscular Immune Globulin
Tetanus Immune Globulin
Rho(D) Immune Globulin
Hepatitis B Immune Globulin (IM/IV)
Rabies Hyperimmune Globulin
Cytomegalovirus Hyperimmune Globulin (CMV)
Allergy Hyperimmune Globulin
All Other Hyperimmune Globulin
Albumin and Plasma Protein Fraction (PPF)
Factor VIII (plasma-derived and recombinant)
Factor IX (plasma-derived and recombinant)
Prothrombin Complex (PCC/PPSB)
Activated Prothrombin Complex & Recombinant Factor VIIa
von Willebrand Factor Complex
Antithrombin III
Alpha-1 Antitrypsin
Fibrin Adhesives
All Other Products